White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition

Qinghai Liu1, Shuhan He2, Leonid Groysman2

  • 1Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

Plos One
|January 4, 2014
PubMed

Insights

The C5 complement protein contributes to white matter injury in chronic cerebral hypoperfusion. Reducing C5 levels decreases inflammation and ischemia in the brain.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • The C5 complement protein is a key inflammatory mediator implicated in stroke and neurodegenerative diseases.
  • Microvascular failure is a proposed mechanism contributing to brain injury.

Purpose of the Study:

  • To investigate the role of C5 in white matter injury during chronic cerebral hypoperfusion.
  • To determine if C5 contributes to inflammation and ischemia in the corpus callosum.

Main Methods:

  • Induction of bilateral carotid artery stenosis in mice to model chronic cerebral hypoperfusion.
  • Measurement of C5 protein deposition in the corpus callosum.
  • Comparison of white matter injury, reactive astrocytes, and microglia in C5-deficient versus C5-sufficient mice.

Main Results:

  • C5 protein deposition increased in the corpus callosum over 30 days post-stenosis, correlating with white matter injury.
  • Systemic serum C5 levels did not change, suggesting a localized cerebral role.
  • C5-deficient mice showed significantly reduced white matter ischemia and neuroinflammation compared to controls.

Conclusions:

  • C5 complement protein plays a critical role in mediating white matter injury in chronic cerebral hypoperfusion.
  • Targeting C5 may offer a therapeutic strategy for conditions involving cerebral hypoperfusion and associated white matter damage.